Your browser doesn't support javascript.
loading
Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019.
Mauro, Pia M; Gutkind, Sarah; Askari, Melanie S; Hasin, Deborah S; Samples, Hillary; Mauro, Christine M; Annunziato, Erin M; Boustead, Anne E; Martins, Silvia S.
Afiliación
  • Mauro PM; Department of Epidemiology, Columbia University Mailman School of Public Health, United States. Electronic address: pm2838@cumc.columbia.edu.
  • Gutkind S; Department of Epidemiology, Columbia University Mailman School of Public Health, United States.
  • Askari MS; Department of Epidemiology, Columbia University Mailman School of Public Health, United States.
  • Hasin DS; Department of Epidemiology, Columbia University Mailman School of Public Health, United States; New York State Psychiatric Institute, United States.
  • Samples H; Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research, United States; Department of Health Behavior, Society & Policy, Rutgers University School of Public Health, United States.
  • Mauro CM; Department of Biostatistics, Columbia University Mailman School of Public Health, United States.
  • Annunziato EM; Department of Epidemiology, Columbia University Mailman School of Public Health, United States.
  • Boustead AE; School of Government & Public Policy, University of Arizona, United States.
  • Martins SS; Department of Epidemiology, Columbia University Mailman School of Public Health, United States.
Drug Alcohol Depend ; 257: 111113, 2024 Apr 01.
Article en En | MEDLINE | ID: mdl-38382162
ABSTRACT

BACKGROUND:

Cannabis use disorder (CUD) treatment prevalence decreased in the US between 2002 and 2019, yet structural mechanisms for this decrease are poorly understood. We tested associations between cannabis laws becoming effective and self-reported CUD treatment.

METHODS:

Restricted-use 2004-2019 National Surveys on Drug Use and Health included people ages 12+ classified as needing CUD treatment (i.e., past-year DSM-5-proxy CUD or last/current specialty treatment for cannabis). Time-varying indicators of medical cannabis laws (MCL) with/without cannabis dispensary provisions differentiated state-years before/after laws using effective dates. Multi-level logistic regressions with random state intercepts estimated individual- and state-adjusted CUD treatment odds by MCLs and model-based changes in specialty CUD treatment state-level prevalence. Secondary analyses tested associations between CUD treatment and MCL or recreational cannabis laws (RCL).

RESULTS:

Using a broad treatment need sample definition in 2004-2014, specialty CUD treatment prevalence decreased by 1.35 (95 % CI = -2.51, -0.18) points after MCL without dispensaries and by 2.15 points (95 % CI = -3.29, -1.00) after MCL with dispensaries provisions became effective, compared to before MCL. Among people with CUD in 2004-2014, specialty treatment decreased only in MCL states with dispensary provisions (aPD = -0.91, 95 % CI = -1.68, -0.13). MCL were not associated with CUD treatment use in 2015-2019. RCL were associated with lower CUD treatment among people classified as needing CUD treatment, but not among people with past-year CUD.

CONCLUSIONS:

Policy-related reductions in specialty CUD treatment were concentrated in states with cannabis dispensary provisions in 2004-2014, but not 2015-2019, and partly driven by reductions among people without past-year CUD. Other mechanisms (e.g., CUD symptom identification, criminal-legal referrals) could contribute to decreasing treatment trends.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de salud: 2_sustancias_psicoativas / 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders / 8_hallucinogen_related_disorders Asunto principal: Cannabis / Abuso de Marihuana / Trastornos Relacionados con Sustancias / Marihuana Medicinal / Alucinógenos Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Drug Alcohol Depend Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de salud: 2_sustancias_psicoativas / 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders / 8_hallucinogen_related_disorders Asunto principal: Cannabis / Abuso de Marihuana / Trastornos Relacionados con Sustancias / Marihuana Medicinal / Alucinógenos Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Drug Alcohol Depend Año: 2024 Tipo del documento: Article
...